KIAA0802 Activators
KIAA0802 Activators encompass a range of chemical compounds that facilitate an increase in the functional activity of KIAA0802 through various and distinct biochemical mechanisms. Forskolin and Ionomycin act by elevating second messengers, cAMP, and calcium, respectively, which activate protein kinases such as PKA and calmodulin-dependent kinases. These kinases can directly or indirectly phosphorylate KIAA0802 or its associated proteins, leading to an enhancement of KIAA0802's signaling capabilities. Similarly, PMA activates PKC, which can phosphorylate substrates influencing KIAA0802's activity, thus promoting itsrole in cellular processes. The inhibitors PD98059, SB203580, U0126, and Epigallocatechin gallate (EGCG) exert their effects by modulating various kinases within the PI3K/Akt, MEK/ERK, and p38 MAPK pathways. These actions can lead to a compensatory activation of alternative signaling routes or reduction of negative regulatory mechanisms that would otherwise suppress KIAA0802 activity.
Additionally, Okadaic Acid and Anisomycin serve as indirect activators by inhibiting phosphatases and inducing stress pathways, respectively, which can result in the phosphorylation and consequent activation of KIAA0802. This is complemented by Sphingosine-1-phosphate, which may enhance KIAA0802 activity via sphingolipid signaling pathways. Calcium ionophores like A23187 (Calcimycin) and Ionomycin also play a critical role by increasing intracellular calcium concentrations, which activate calcium-dependent signaling cascades that can affect the phosphorylation status and function of KIAA0802. By manipulating various cellular signals, these KIAA0802 activators collectively ensure the upregulation of KIAA0802's functional activity without direct binding interactions, highlighting the intricacy of intracellular signaling networks and their impact on specific protein functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which in turn activates PKA. PKA phosphorylates various proteins that can interact with KIAA0802, either stabilizing its active conformation or enhancing its interaction with other signaling molecules. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, which may phosphorylate KIAA0802 or its interacting partners, enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can modulate intracellular signaling pathways. PKC-mediated phosphorylation can lead to changes in KIAA0802 functionality by altering its conformation or promoting its association with signaling complexes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that can lead to the accumulation of upstream signaling molecules which may include kinases that phosphorylate KIAA0802, indirectly increasing its activation state. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, its action can result in the redirection of signaling traffic toward alternative pathways that enhance the activity of KIAA0802 through phosphorylation or allosteric modulation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of many proteins, which could include KIAA0802, thus enhancing its activity indirectly. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate is involved in intracellular signaling and may enhance KIAA0802 activity by modulating signaling pathways that lead to its activation, such as by influencing its protein-protein interactions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a tyrosine kinase inhibitor that may indirectly enhance KIAA0802's activity by decreasing competitive phosphorylation events, thereby favoring KIAA0802's role in relevant signaling cascades. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress response pathways such as JNK and p38 MAPK. The resultant cellular response could enhance KIAA0802 activity by promoting its incorporation into stress-related signaling complexes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, similar to Ionomycin. This elevation can stimulate calcium-dependent kinases and phosphatases that modulate KIAA0802 activity by affecting its phosphorylation status. | ||||||